By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Santen Pharmaceutical Co., Ltd. 

3-9-19 Shimo-Shinjo Higashi Yodogawa-ku

Osaka    533  Japan
Phone: 81-0-6-3217000 Fax: 81-0-6-3285082



Company News
Santen Pharma Announces Phase III SAKURA Program Topline Results In Patients With Non-Infectious Uveitis Of The Posterior Segment 11/28/2016 6:25:04 AM
Santen Pharma Bags Microshunt Maker InnFocus for $225 Million 7/19/2016 6:36:40 AM
TRACON Pharmaceuticals, Inc. (TCON) Announces IND Filing Of DE-122 (TRC105) For The Treatment Of Wet Age-Related Macular Degeneration By Santen Pharmaceutical 7/1/2015 6:59:45 AM
Santen Pharmaceutical Reports Consolidated Performance For The Fiscal Year Ended March 31, 2015 5/12/2015 8:23:08 AM
Santen Pharmaceutical Announces Assignment Of Its Anti-Rheumatic Pharmaceuticals Business To Hyperion Pharma 5/12/2015 7:34:13 AM
R-Tech Ueno: Announcement On Acquisition Of The Right To Develop And Commercialize DE-105 From Santen Pharmaceutical 4/27/2015 10:54:10 AM
Santen Pharmaceutical Announces Approval Of Ikervis For EU Marketing Authorization 3/25/2015 8:00:04 AM
Santen Pharmaceutical Release: Increase Of Capital For A Consolidated Subsidiary In Europe 9/25/2014 7:55:10 AM
Santen Pharmaceutical Facilitates Compliance, Promotes Safety, And Supports Growth With Oracle (ORCL) Argus Cloud Service 7/9/2014 2:10:24 PM
Merck & Co., Inc. (MRK) Signs Sale Agreement With Santen Pharmaceutical For Merck's Ophthalmology Products In Japan And Key Markets In Europe And Asia Pacific 5/13/2014 6:40:49 AM